Suchergebnisse - "McQueen, R Brett"

PubPharm (102)

31

Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment

enthalten in: PharmacoEconomics | 2021

von McQueen, R. | Slejko, J.

32

Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment

enthalten in: PharmacoEconomics | 2021

von McQueen, R. | Slejko, J.

33

Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment

enthalten in: PharmacoEconomics | 2021

von McQueen, R. | Slejko, J.

34

Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement

enthalten in: PharmacoEconomics - open | 2021

von Quinlan, T. | Schroeder, B. | Kwon, S. | +5

35

Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement

enthalten in: PharmacoEconomics - open | 2021

von Quinlan, T. | Schroeder, B. | Kwon, S. | +5

36

Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement

enthalten in: PharmacoEconomics - open | 2021

von Quinlan, T. | Schroeder, B. | Kwon, S. | +5

37

Patient and Payer Preferences for Additional Value Criteria

enthalten in: Frontiers in pharmacology | 2021

von Jakab, I. | Whittington, M. | Franklin, E. | +4

38

Alternative Approaches to Quality-Adjusted Life-Year Estimation Within Standard Cost-Effectiveness Models : Literature Review, Feasibility Assessment, and Impact Evaluation

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2020

von Carlson, J. | Brouwer, E. | Kim, E. | +2

39

A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer

enthalten in: PharmacoEconomics | 2020

von Gao, W. | Muston, D. | Monberg, M. | +8

40

A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer

enthalten in: PharmacoEconomics | 2020

von Gao, W. | Muston, D. | Monberg, M. | +8